Giancarlo Pruneri, MD, University of Milan, Milan, Italy, discusses whether molecular profiling will replace traditional pathological markers or will be used side by side. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.